Awarded
INHIBITEUR DE LA C1 ESTERASE INDICATION : TRAITEMENT/PROPHYLAXIE AU LONG COURT DES CRISES D'OEDEMES
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- TAKEDA FRANCE SAS
- Contract value
- €894,062
- Published
- 29 Apr 2025
- Awarded
- 3 Feb 2025
- Contract start
- 1 Jun 2025
- Contract end
- 31 May 2029stated
- Region
- Rhône